Medicine and Dentistry
Breast Cancer
100%
Neoplasm
72%
Primary Hyperparathyroidism
41%
Recurrent Disease
31%
Hormone Therapy
31%
Parathyroid Hormone
28%
Parathyroid
28%
Diseases
24%
Gene Expression Profiling
23%
Aromatase Inhibitor
22%
Parathyroid Tumor
21%
Estrogen Receptor
20%
Oncology
19%
Surgery
19%
Surgeon
18%
Parathyroid Adenoma
18%
Adjuvant Chemotherapy
17%
Calcium Sensing Receptor
15%
Gene Expression
14%
Parathyroidectomy
14%
Health Care Cost
13%
Isotopes of Calcium
13%
Papillary Thyroid Cancer
12%
Estrogen Receptor Positive Breast Cancer
11%
Hyperparathyroidism
11%
Postmenopause
10%
Cancer
10%
Biological Marker
10%
Letrozole
10%
Thyroidectomy
10%
Clinical Trial
10%
Lymph Node
9%
Quadrantectomy
9%
Retroperitoneal Lymph Node Dissection
9%
Hormone Receptor
9%
Parathyroid Gland
9%
Pheochromocytoma
9%
Anastrozole
9%
Exemestane
9%
Isoprenaline
9%
Adenoma
9%
Methoxy Isobutyl Isonitrile Technetium Tc 99m
8%
(3 Iodobenzyl)guanidine I 131
8%
(3 Iodobenzyl)guanidine
8%
Adjuvant Therapy
8%
Iodine 131
8%
Parathyroid Carcinoma
8%
Autotransplantation
8%
Biopsy Technique
8%
Malignant Neoplasm
8%
Keyphrases
Breast Cancer
60%
Tumor
39%
Primary Hyperparathyroidism (pHPT)
37%
Neoadjuvant
23%
Parathyroid Tumors
22%
Endocrine Therapy
21%
Intact Parathyroid Hormone (iPTH)
21%
Clinical Outcomes
20%
Adjuvant Chemotherapy
19%
Estrogen Receptor
17%
Breast Cancer Patients
17%
Parathyroid Adenoma
17%
Recurrence Score
15%
Gene Expression
15%
Clinical Practice Guidelines
15%
Calcium-sensing Receptor (CaSR)
15%
Breast Reconstruction
15%
Ki-67
14%
Estrogen Receptor-positive Breast Cancer
14%
Chemotherapy
13%
Aromatase Inhibitors
13%
Surgical Management
13%
Surgical Outcomes
13%
Disease-free Survival
12%
TAILORx
12%
Neoadjuvant Endocrine Therapy
12%
Papillary Thyroid Cancer
12%
Gene Signature
12%
Parathyroidectomy
12%
Rat Brain
11%
Gene Expression Profile
11%
Confidence Interval
11%
Postmenopausal Women
11%
Adenoma
11%
Breast
11%
Hormone Receptor-positive
10%
Early Breast Cancer
10%
Letrozole
10%
Patients with Breast Cancer
10%
Prognostic Score
10%
Parathyroid Glands
9%
Breast Tumor
9%
Melanoma
9%
Microarray
9%
Oncology
9%
Parathyroid Tissue
9%
Breast Cancer Susceptibility Gene 1 (BRCA1)
9%
Saccharomyces Cerevisiae
9%
Hyperparathyroidism
9%
ACOSOG
9%